Further, RA patients have increased EBV-specific CD8+ T cells (Lünemann et al., 2008), yet these cells have a reduced ability to kill EBV-infected B cells when compared to the same subset of EBV-specific CD8+ T cells from healthy controls (Takei et al., 2001). This evidence concerns the gene CD8A and rheumatoid arthritis.